Status:
WITHDRAWN
Dim Light at Night in Patients With Obstructive Sleep Apnea
Lead Sponsor:
Ulysses Magalang MD
Conditions:
Obstructive Sleep Apnea (OSA)
Eligibility:
All Genders
18-60 years
Phase:
NA
Brief Summary
With the advent of electricity, light at night has become a ubiquitous part of our society. The main purpose of this study is to determine whether sleeping with dim light (40 lux), the brightness of ...
Detailed Description
The primary objective of this study is to determine whether sleeping with dLAN (40 lux) for 5 consecutive nights will result in increased markers of inflammation compared to sleeping in darkness (\< 1...
Eligibility Criteria
Inclusion
- • 18 -60 years of age.
- Willing and able to give informed consent
- AHI \>10 episodes per hour based on a prior PSG.
- Patients who have been started on treatment for OSA with either Continuous Positive Airway Pressure (CPAP) or dental device will be eligible for the study as long as they have been compliant with treatment for at least 30 days.
Exclusion
- • Incapable of giving informed consent
- Under the age of 18
- Currently sleeping with lights on in the bedroom
- Excessive alcohol consumption
- Excessive alcohol use is defined as:
- More than 3 glasses of wine a day
- More than 3 beers a day
- More than 60 mL of hard liquor a day
- Room air oxyhemoglobin saturation \< 88%
- Use of home oxygen
- Use of corticosteroids and other immunosuppressive medications.
- Diagnosis of: HIV, Connective Tissue Disease (Lupus, Rheumatoid arthritis), Inflammatory Bowel Disease.
Key Trial Info
Start Date :
February 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2018
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT01853891
Start Date
February 1 2013
End Date
June 1 2018
Last Update
July 30 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Ohio State University
Columbus, Ohio, United States, 43221